文献速递肝胆胰外科围术期管理与 ERAS

高危胰肠吻合与全胰切除术在胰十二指肠切除术后的结局与生活质量比较

High-risk Pancreatic Anastomosis Versus Total Pancreatectomy After Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
PubMed 文献 · Ann Surg · 2021-03-04

本研究比较高危胰肠吻合(HR-PD)与术中转为全胰切除(C-TP)患者的术后结局及生活质量。结果显示C-TP组术后出血、胃排空延迟、脓毒症及严重并发症率更低、住院更短,但内分泌和外分泌功能不全更常见且糖尿病相关生活质量更差。结论认为C-TP仅应在少数精选病例并充分告知后考虑。

要点

  • C-TP组术后出血、胃排空延迟、脓毒症及Clavien-Dindo≥3并发症率均低于HR-PD组。
  • C-TP组中位住院时间短于HR-PD组,但两组死亡率相当。
  • C-TP组全部出现内分泌和外分泌功能不全,糖尿病相关生活质量更差。

核心结论

  • C-TP仅应在少数精选病例并充分告知后考虑替代高危胰肠吻合。

研究设计与样本

  • 回顾性比较2017年7月至2019年12月间接受PD或TP的患者,HR-PD依据alternative fistula risk score定义。

主要发现

  • C-TP组术后出血发生率15% vs HR-PD组28%,胃排空延迟16% vs 34%,脓毒症10% vs 31%,Clavien-Dindo≥3并发症19% vs 31%,均P<0.05。
  • C-TP组中位住院时间10天 vs HR-PD组21天(P<0.05)。
  • HR-PD组POPF发生率为39%。
  • 两组死亡率相当(3% vs 4%)。
  • C-TP组全部患者出现内分泌和外分泌功能不全,HR-PD组分别为13%和63%,且C-TP组糖尿病相关生活质量更差。

临床怎么用

  • 在高危胰肠吻合患者中,C-TP可降低术后出血、胃排空延迟、脓毒症及严重并发症并缩短住院,但需权衡功能不全和生活质量下降。
  • 仅应在少数精选病例并充分告知后考虑C-TP替代HR-PD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate TP as an alternative to PD in patients at high-risk for popf. BACKGROUND: Outcomes of high-risk PD (HR-PD) and TP have never been compared. METHODS: All patients who underwent PD or TP between July 2017 and December 2019 were identified. HR-PD was defined according to the alternative fistula risk score. Postoperative outcomes (primary endpoint), pancreatic insufficiency, and quality of life after 12 months of follow-up (QoL) were compared between HR-PD or planned PD intraoperatively converted to TP (C-TP). RESULTS: A total of 566 patients underwent PD and 136 underwent TP during the study period. One hundred one (18%) PD patients underwent HR-PD, whereas 86 (63%) TP patients underwent C-TP. Postoperatively, the patients in the C-TP group exhibited lower rates of postpancreatectomy hemorrhage (15% vs 28%), delayed gastric emptying (16% vs 34%), sepsis (10% vs 31%), and Clavien-Dindo ≥3 morbidity (19% vs 31%) and had shorter median lengths of hospital stay (10 vs 21 days) (all P < 0.05). The rate of POPF in the HR-PD group was 39%. Mortality was comparable between the 2 groups (3% vs 4%). Although general, cancer- and pancreas-specific QoL were comparable between the HR-PD and C-TP groups, endocrine and exocrine insufficiency occurred in all the C-TP patients, compared to only 13% and 63% of the HR-PD patients, respectively, and C-TP patients had worse diabetesspecific QoL. CONCLUSIONS: C-TP may be considered rather than HR-PD only in few selected cases and after adequate counseling.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Marchegiani G, Perri G, Burelli A, et al. High-risk Pancreatic Anastomosis Versus Total Pancreatectomy After Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis. Ann Surg. 2021. PMID: 33914471. doi:10.1097/SLA.0000000000004840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。